Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Masimo Corporation (NASDAQ:MASI) disclosed Friday that it received unsolicited offers from potential acquirers for its ...

Apart from focusing on its consumer business separation, Masimo continues to expand its product portfolio. Earlier this month ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing ...

Details How Independent Third Parties and the Evidence in Legal Proceedings Have Consistently Refuted Masimo’s "Defensive ... (the "Annual Meeting"), set for September 19. The full text of ...

Masimo SET ® originated in Founder and CEO Joe Kiani’s desire to find a way to monitor the oxygen saturation of those most precious of patients – neonatal infants – accurately and reliably ...

1. Published clinical studies on pulse oximetry and the benefits of Masimo SET ® can be found on our website at www.masimo.com. Comparative studies include independent and objective studies which ...

Masimo Corp.’s annual shareholder meeting, scheduled for Sept. 19, will determine whether Joe Kiani will remain as chairman of the company he co-founded in 1989. The Irvine maker of non-invasive ...